Genomma Lab Internacional S.A.B. de C.V (LABB) - Total Assets
Based on the latest financial reports, Genomma Lab Internacional S.A.B. de C.V (LABB) holds total assets worth MX$24.80 Billion MXN (≈ $1.43 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check LABB total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Genomma Lab Internacional S.A.B. de C.V - Total Assets Trend (2005–2025)
This chart illustrates how Genomma Lab Internacional S.A.B. de C.V's total assets have evolved over time, based on quarterly financial data. Explore Genomma Lab Internacional S.A.B. de C.V long-term investment allocation to see how much of total assets are deployed in long-term investments.
Genomma Lab Internacional S.A.B. de C.V - Asset Composition Analysis
Current Asset Composition (December 2025)
Genomma Lab Internacional S.A.B. de C.V's total assets of MX$24.80 Billion consist of 53.9% current assets and 46.1% non-current assets.
| Asset Category | Amount (MXN) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | MX$0.00 | 12.9% |
| Accounts Receivable | MX$4.50 Billion | 18.9% |
| Inventory | MX$1.84 Billion | 7.7% |
| Property, Plant & Equipment | MX$0.00 | 0.0% |
| Intangible Assets | MX$5.53 Billion | 23.2% |
| Goodwill | MX$45.81 Million | 0.2% |
Asset Composition Trend (2005–2025)
This chart illustrates how Genomma Lab Internacional S.A.B. de C.V's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see LABB market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Genomma Lab Internacional S.A.B. de C.V's current assets represent 53.9% of total assets in 2025, an increase from 0.0% in 2005.
- Cash Position: Cash and equivalents constituted 12.9% of total assets in 2025, down from 17.2% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 23.0% of total assets, an increase from 1.0% in 2005.
- Asset Diversification: The largest asset category is intangible assets at 23.2% of total assets.
Genomma Lab Internacional S.A.B. de C.V Competitors by Total Assets
Key competitors of Genomma Lab Internacional S.A.B. de C.V based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867
|
China | CN¥8.25 Billion |
|
Eris Lifesciences Limited
NSE:ERIS
|
India | Rs71.60 Billion |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
|
China | CN¥13.81 Billion |
|
Lotus Pharmaceutical Co Ltd
TW:1795
|
Taiwan | NT$106.15 Billion |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535
|
China | CN¥15.69 Billion |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550
|
China | CN¥3.23 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Sun Pharma Advanced Research Company Limited
NSE:SPARC
|
India | Rs3.22 Billion |
Genomma Lab Internacional S.A.B. de C.V - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.79 | 1.56 | 1.76 |
| Quick Ratio | 1.53 | 1.29 | 1.42 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | MX$6.01 Billion | MX$4.66 Billion | MX$5.31 Billion |
Genomma Lab Internacional S.A.B. de C.V - Advanced Valuation Insights
This section examines the relationship between Genomma Lab Internacional S.A.B. de C.V's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.24 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | -1.0% |
| Total Assets | MX$23.83 Billion |
| Market Capitalization | $846.86 Million USD |
Valuation Analysis
Below Book Valuation: The market values Genomma Lab Internacional S.A.B. de C.V's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Genomma Lab Internacional S.A.B. de C.V's assets decreased by 1.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Genomma Lab Internacional S.A.B. de C.V (2005–2025)
The table below shows the annual total assets of Genomma Lab Internacional S.A.B. de C.V from 2005 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | MX$23.83 Billion ≈ $1.37 Billion |
-1.03% |
| 2024-12-31 | MX$24.08 Billion ≈ $1.39 Billion |
+16.36% |
| 2023-12-31 | MX$20.70 Billion ≈ $1.19 Billion |
-4.21% |
| 2022-12-31 | MX$21.61 Billion ≈ $1.24 Billion |
+0.30% |
| 2021-12-31 | MX$21.54 Billion ≈ $1.24 Billion |
-2.66% |
| 2020-12-31 | MX$22.13 Billion ≈ $1.27 Billion |
+14.95% |
| 2019-12-31 | MX$19.25 Billion ≈ $1.11 Billion |
+6.51% |
| 2018-12-31 | MX$18.08 Billion ≈ $1.04 Billion |
+13.80% |
| 2017-12-31 | MX$15.89 Billion ≈ $914.23 Million |
+1.13% |
| 2016-12-31 | MX$15.71 Billion ≈ $904.04 Million |
-10.91% |
| 2015-12-31 | MX$17.63 Billion ≈ $1.01 Billion |
-30.66% |
| 2014-12-31 | MX$25.43 Billion ≈ $1.46 Billion |
+46.54% |
| 2013-12-31 | MX$17.35 Billion ≈ $998.66 Million |
+33.56% |
| 2012-12-31 | MX$12.99 Billion ≈ $747.73 Million |
+41.32% |
| 2011-12-31 | MX$9.19 Billion ≈ $529.12 Million |
+57.68% |
| 2010-12-31 | MX$5.83 Billion ≈ $335.57 Million |
+37.47% |
| 2009-12-31 | MX$4.24 Billion ≈ $244.11 Million |
+49.36% |
| 2008-12-31 | MX$2.84 Billion ≈ $163.44 Million |
+137.84% |
| 2007-12-31 | MX$1.19 Billion ≈ $68.72 Million |
+62.54% |
| 2006-12-31 | MX$734.61 Million ≈ $42.28 Million |
+54.43% |
| 2005-12-31 | MX$475.69 Million ≈ $27.38 Million |
-- |
About Genomma Lab Internacional S.A.B. de C.V
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products t… Read more